← Back to Search

HPV Self-Collection for Human Papillomavirus

N/A

Waitlist Available

Led By Deanna Kepka, PhD, MPH

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Aged 25-65 years during the study measurement period

Be older than 18 years old

Must not have

Individuals without a cervix

Receiving hospice and/or palliative care during any part of the measurement period

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to develop and test HPV self-collection programs for women who are overdue for cervical cancer screening. The study will create protocols for in-clinic and home-based HPV self-collection programs and a follow

Who is the study for?

The HPV Self-Collection Program is for women and individuals with a cervix, aged 24-64 who haven't had a Pap test in the last 3.5 years or those aged 30-65 without an HPV test in the past 5.5 years. Participants must be overdue for cervical cancer screening and have visited a participating clinic.

What is being tested?

This study aims to evaluate the effectiveness of mailing out HPV self-collection kits to women overdue for cervical cancer screening and offering them as an option at clinics. It focuses on implementing these programs rather than testing medical devices or safety.

What are the potential side effects?

Since this trial does not involve any medical procedures, drugs, or device testing but instead evaluates program implementation, there are no direct side effects associated with participation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 25 and 65 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I do not have a cervix.

Select...

I am receiving comfort care for my illness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Clinic Level Implementation Rate

Secondary study objectives

At home utilization rate

Follow-up care rate

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: HPV Self-CollectionExperimental Treatment1 Intervention

Patients at partnering clinics who are enrolled in the clinics' HPV self-collection program(s). The requirements for being enrolled in the program are based off of the American Cancer Society's recommendation for cervical cancer screening.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HPV Self-Collection

2021

N/A

~820

0 / 3Eligibility criteria met